poisar

Stock

Revelation Biosciences, Inc. REVB

$1.03+5.66%

Overview

REVB market data

Price History

REVB price chart · 1M
O
0.996500
H
1.03
L
0.996500
C
1.03
Vol
304.00
Source
US equities market feed
Observed
Aug 27, 2026, 12:00 AM
Cadence
Five-minute page cache; daily and stored hourly bars
Status
fresh

Key Stats & Performance

Open
$1.00
Previous Close
$0.97
Day High
$1.03
Day Low
$1.00
52 Week High
$1.20
52 Week Low
$0.89
7 Day Return
-13.08%
30 Day Return
-4.63%
90 Day Return
-6.36%
1 Year Return
-10.43%
Daily Notional Volume
$313.1
Latest daily bar volume multiplied by its closing price.

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$14.36
Diluted earnings per share over the trailing twelve months.
Beta
-0.08
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$0.88 – $11.60
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $4.4M · P/B 0.53.

Company News

4 captured
Revelation Biosciences Selected Avance Clinical To Serve As CRO For Phase 2/3 Adaptive-Design TITAN Study For Evaluating Gemini In Patients With Acute Kidney InjuryBenzinga · Aug 19, 2026, 1:05 PM
Revelation Biosciences Q2 EPS $(0.87) Beats $(0.88) EstimateBenzinga · Aug 6, 2026, 9:18 PM
Revelation Biosciences Cites Independent Market Assessment Indicating A $94B Total Addressable Market For Its Gemini Kidney TreatmentBenzinga · Aug 3, 2026, 1:03 PM
Revelation Biosciences' Board Implements Shareholder Rights Plan, Declares Dividend Distribution Of One Right For Each Outstanding Common StockBenzinga · Jul 10, 2026, 8:10 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock